CLOCK and cancer: The results showed that the expression levels of CLOCK, along with CBX5, CHN1, CNN3, FNDC1, PALLD, and SULF1, were significantly elevated in metastatic cancer tissues compared to primary cancer tissues (Fig. 5G).